Cerebral ischemia was induced in unanesthe tized gerbils using bilateral carotid artery ligations. The effects of 20 min of global ischemia on the concentrations of prostaglandin F2a (PGF2a), PGE2, 6-keto-prostaglandin Fla (6-keto-PGFla), and thromboxane B2 were deter mined after 0-24 h of reperfusion. Ischemia had little ef fect on eicosanoid production, but significant increases were observed by 5 min of reperfusion, with maximal levels reached by 15 min of reperfusion. PGF2a was the most concentrated prostaglandin in postischemic brain, whereas PGE2 was most concentrated in control cerebra. versity, Kent, OR 44242, U.S.A.
Cerebral ischemia induces the rapid accumula tion of unesterified fatty acids, including arachi donic acid (Bazan, 1970) . The cyclooxygenase pathway converts some of the unesterified arachi donate to prostanoids, upon tissue reperfusion (Gaudet et aI. , 1980) . Prostaglandin synthesis is stimulated by a variety of CNS pathologies (Wolfe and Marner, 1975) , and the degree of stroke-in duced tissue damage can be predicted by the levels of prostaglandins accumulated in CSF (Carasso et aI., 1977) . Inhibition of cyclooxygenase activity ap pears to protect traumatized brain, because indo methacin enhances postischemic reperfusion (Hal lenbeck and Furlow, 1979) , and protects hippo campal slices from posthypoxic reoxygenation damage (Taylor et aI. , 1985) . Cyclooxygenase inhi-bition also blocks the evoked release of excitatory amino acids from isolated nerve terminals (Dorman et aI. , 1986) and these transmitters have been implicated in nerve tissue damage (Clark and Rothman, 1987 ). It appears that eicosanoids are in dicators of ischemic brain damage and they may also be involved in the damage processes.
Barbiturate anesthesia provides a mechanism for evaluating the role of eicosanoids in ischemic brain damage. Barbiturates attenuate the ischemia-in duced accumulation of unesterified fatty acids (Flamm et aI. , 1977; Yoshida et aI. , 1983) . They also inhibit cold trauma-induced vasogenic edema (Clasen et aI., 1974) , the ischemia-induced loss of neurons in the CA 1 region of the hippocampus (Kirino et aI. , 1985) , and the mortality associated with ischemic brain damage (Jarrott and Domer, 1980; Yoshida et aI. , 1983; Edgehouse and Dorman, 1987) . Therefore, the protective effects of barbitu rates should be reflected by altered metabolism of agents involved in the damage processes.
The effects of 20 min of ischemia and 0-24 h of reperfusion on eicosanoid concentrations were as-R. V.DORMAN sessed with the gerbil stroke model. The eico sanoids examined were prostaglandin F20. (PGF20.)' prostaglandin E2 (PGE2), 6-keto-prostaglandin Flo. (6-keto-PGFlo., and thromboxane B2 (TXB2)· PGF20. and PGE2 were examined because they are major eicosanoids produced by nerve tissues. TXB2 and (6-keto-PGFlo.), and thromboxane B2 (TXB2). PGF20. known vascular effects. Time courses for the pro duction of these eicosanoids were performed in awake and pentobarbital-anesthetized gerbils. Al though pentobarbital has marked effects on metab olism, edema, and mortality, it did not reduce the ischemia-induced accumulation of PGF20.' 6-keto PGFlo.' or TXB2 and had minimal effects on PGE2 concentrations.
METHODS
Male gerbils (60-90 g) were anesthetized with pento barbital (Nembutal; Abbott Laboratories, North Chi cago, IL, U.S.A. ) 36 mg/kg, i.p. prior to major surgery (Edgehouse and Dorman, 1987) . The necks were disin fected and opened. The carotid arteries were cleared of surrounding connective tissue and each was loosely looped with a waxed thread. The wounds were closed with skin clips and the animals were allowed to recover overnight, prior to induction of ischemia. Pentobarbital treated animals received the anesthetic 30 min before the induction of ischemia. The animals were restrained with a wide elastic band on a surgical board. The skin clips were removed and the carotid arteries located using the waxed threads. Microvascular clamps were applied to each artery and the restraints were removed, because an imals immediately become quiescent. The clamps were removed at 20 min and the neck wounds were closed with skin clips. Animals were killed by decapitation at 0,5, lO, 15 , 30, 60 , and 120 min and 24-h postclamp. Survival of the ischemia/reperfusion was 91 % for unanesthetized gerbils and 97% for the pentobarbital-treated animals. The brains were removed and the cerebra were dissected from other brain regions.
The total lipids were extracted with hexane:isopro panol (3:2, voVvol) (Hara and Radin, 1978) within 30 s of killing. The rapid removal and extraction of the tissues prevented postmortem increases in all assayed eico sanoids, as shown by the low levels found in control cer ebra. The extracts were centrifuged to pellet-precipitated protein, passed through 0.65 fLm pore nylon filters, and evaporated under N2• Eicosanoids were separated from other lipids by silicic acid column chromatography (Saunders and Horrocks, 1984) , with the eicosanoids being concentrated in the methyl formate fraction. These fractions were evaporated under N2, reconstituted in ra dioimmunoassay buffer, and sampled for quantitation. The extraction and purification procedures allow for >90% recovery of the eicosanoids.
PGF2a and 6-keto-PGF.a were quantitated using mono clonal antibodies (provided by Dr. R. Fertel). The poly clonal antibodies against PGE2 and TXB2 were purchased from Advanced Magnetics, Inc., as were all cold stan dards. The pH]eicosanoids were obtained from Amer sham, Inc. Each assay was characterized for inter-and intraassay variability, as well as cross-reactivity. The in traassay and interassay coefficients of variation for J Cereb Blood Flow Metab, Vol. 8, No.4, 1988 PGF2a were 4. 6 and lO.3%, respectively, whereas they were 2.4 and 7.3% for PGE2, 2.1 and 14.3% for 6-keto PGF.a, and 1.2 and 7.4% for TXB2• The cross-reactivity of the PGF2a antibody was 0.04, 0.01, and 0.1% for 6keto-PGF.a, PGE2, and TXB2, respectively, whereas the cross-reactivity of the antibody against 6-keto-PGF.a was 0.08, 0.01, and 0.01% for PGF2a, PGE2, and TXB2, re spectively. The antibody against PGE2 cross-reacted 2.0, 0.01, and 0.01% with PGF2a, 6-keto-PGF.a, and TXB2, respectively, and the antibody against TXB2 cross reacted <0.01% with the other eicosanoids. It was also determined that nonpolar and phospholipids interfered with the assays, which confirmed the importance of the above column purifications. Analysis of variance and Newman-Keuls pairwise comparison test were used to estimate levels of significant differences between unan esthetized and pentobarbital-treated animals. The values obtained for PGF2a and PGE2 are expressed as nano grams per cerebrum ± SEM, whereas those for 6-keto PGFla and TXB2 are shown as picograms per cerebrum ± SEM. Each value represents duplicate determinations at three different dilutions taken from at least five an imals. Also, the results are expressed as picograms or nanograms per cerebrum because the extraction proce dure precludes protein estimates and tissue weighing was avoided to reduce postmortem eicosanoid metabolism.
RESULTS
The effects of cerebral ischemia and reperfusion on PGF2a and PGE2 concentrations in unanesthe tized and pentobarbital-treated gerbils are shown in Fig. L Control levels for PGF20. and PGE2 were 1.0 ± 0.2 and 1,8 ± 0.3 ng/cerebrum, respectively. Neither eicosanoid increased significantly during 20 min of ischemia, but there was a 12-fold increase in PGF20. during 5 min of reperfusion, whereas PGE2 increased 261%. PGF20. concentrations increased to a maximum of 29.3 ± 3.2 ng/cerebrum at 15 min of reperfusion, then declined to control levels by 24 h. PGE2 increased to a maximum of 17.1 ± 1.9 ng/ce rebrum by 15 min of reperfusion, and also returned to control levels by 24 h.
Pentobarbital pretreatment did not affect PGF20. concentrations during the ischemic period, or during 10 min of reperfusion. However, the con centrations of this eicosanoid were 35, 47, and 72% above those observed in unanesthetized animals at 15, 30, and 120 min of reperfusion, respectively (p < 0.05). Pentobarbital had no significant effect on PGE2 concentrations, except a 38% reduction at 120 min of reperfusion (p < 0.05).
The effects of ischemia and pentobarbital on 6keto-PGFlo. and TXB2 concentrations are shown in Figure 2 , The control levels of 6-keto-PGFI0. and TXB2 were 188 ± 33 and 48 ± 7 pg/cerebrum, re spectively. The concentration of 6-keto-PGFI0. showed a nonsignificant increase during 20 min of ischemia, but did increase 90% during 5 min of re perfusion. The concentration of this eicosanoid reached a maximum of 599 ± 80 pg/cerebrum by 15 min of reperfusion and returned to control levels by 24 h. TXB2 showed a nonsignificant increase during 20 min of ischemia. TXB2 reached a maximum con centration of 584 ± 132 pg/cerebrum by 15 min of reperfusion, followed by a return to control levels by 24 h. A 129% increase in 6-keto-PGFla concentration was observed at the end of the ischemic period, when animals were pretreated with pentobarbital (p < 0.05). There were no significant increases in 6keto-PGF la concentrations related to pentobarbital treatment, at any reperfusion time examined. Pen tobarbital also caused a modest increase in TXB2 levels during 20 min of ischemia, but there were no significant differences related to barbiturate pre treatment through the remainder of the time course.
DISCUSSION
Cerebral ischemia induces phospholipid catabo lism and results in the accumulation of unesterified fatty acids. The unesterified, polyunsaturated fatty acids can be oxidized via cyclooxygenase, lipoxy- genase, and other peroxidation pathways. These events depend on the presence of molecular ox ygen. Time courses for the ischemia-induced pro duction of four major eicosanoids were performed in unanesthetized gerbil cerebra, because previous studies included general anesthetics, which are known to alter nerve tissue metabolism. Tw enty minutes of ischemia had little effect on prosta glandin formation, but tissue reperfusion supported marked elevations in PGF2a, PGE2, 6-keto-PGFla, and TXB2. These results confirm the cyclooxy genase requirement for the molecular oxygen sup plied during tissue reperfusion (Gaudet et aI., 1980) . The observation that reperfusion stimulated PGF2a production more than PGE2 is consistent with previous reports (Gaudet et aI., 1980; Bhakoo et aI., 1984) . In all cases, the rates of eicosanoid production declined between 5 and 10 min of reperfusion. This may be related to the effects of ischemia on CBF, because hyperperfusion occurs at early reperfusion times, followed by hypoperfusion (Steen et aI., 1978; To dd et aI., 1986 ) and blood flow alterations may affect oxygen delivery and prostaglandin clear ance. In all cases, the concentrations of the quanti-R. V. DORMAN tated eicosanoids peaked at 15 min of reperfusion, which was later than had been observed in anesthe tized gerbils exposed to 5 min of bilateral carotid artery ligations (Gaudet et ai., 1980) and earlier than reported for anesthetized gerbils exposed to 60 min of cerebral ischemia (Bhakoo et ai., 1984) . All prostaglandins then declined to control levels by 24 h of reperfusion. This is consistent with the re moval of the substrate for the cyclooxygenase pathway, because arachidonic acid levels also de cline during postischemic reperfusion (Yoshida et ai., 1983; Dorman, unpublished observations) .
Pentobarbital did not have the expected effects on eicosanoid synthesis in postischemic brain. Bar biturates have been shown to reduce ischemia induced arachidonate accumulation by �25% (Flamm et aI., 1977; Yoshida et aI., 1983; Dorman, unpublished observations) . Therefore, it might be expected that pentobarbital would reduce pros tanoid levels. However, the presence of anesthetic doses of pentobarbital did not reduce the accumu lation of PGFZOl' 6-keto-PGFJOl, or TXBz at any re perfusion time examined. In fact, it appeared that pentobarbital anesthesia increased PGF Z Ol concen trations at 15-120 min of reperfusion. It also in duced increased 6-keto-PGFJa concentrations at early times. Only PGEz showed some benefit re lated to pentobarbital anesthesia, because its con centration was reduced at 120 min of reperfusion. It appears that the barbiturate-mediated reductions in ischemia-induced fatty acid accumulation are either insufficient to affect cyclooxygenase activities, or affect free fatty acids pools that are not available to this metabolic pathway.
Pentobarbital has such dramatic effects on the course of ischemic brain damage that it must affect agents involved in the damage processes. Pento barbital reduces ischemia-induced fatty acid accu mulation and attenuates the edema and mortality associated with cerebral ischemia (Yoshida et ai., 1983; Edgehouse and Dorman, 1987) . Pentobarbital also prevents KCN-induced seizures and Ca 2 + in flux (Johnson et ai., 1987) . Therefore, PGFZa' 6keto-PGFJa, and TXBz may not be involved in the necrotic processes related to cerebral ischemia, be cause their concentrations were not reduced by pentobarbital anesthesia. Although PGEz concen trations were reduced by this anesthetic, the reduc tions occurred late in the course of reperfusion, and may not be related to ischemia-induced tissue damage. It may also be that the brain damage de pends on increased concentrations of eicosanoids that were not investigated during this study. This possibility is being examined, as well as the in volvement of other lipid peroxidation pathways in ischemic brain damage.
